Announcements Trials

Browse Landscape

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Carcinoma 5 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Mouth Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Skin Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell 2 Laryngeal Neoplasms 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Breast Neoplasms 2 Vaccinia 1 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma 1 Resectable Non-small Cell Lung Cancer 1 Rectal Neoplasms 1 Prostatic Neoplasms 1

Interventions

selpercatinib 1 fludarabine 1 aldesleukin 1 Nivolumab 1 Ipilimumab 1 Cyclophosphamide 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × cemiplimab × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡